* Neuronetics Inc STIM.OQ reported a quarterly adjusted
loss
of 28 cents per share for the quarter ended in September. The
mean expectation of five analysts for the quarter was for a loss
of 42 cents per share.
* Revenue rose 19.6% to $16.50 million from a year ago;
analysts
expected $15.02 million.
* Neuronetics Inc's reported EPS for the quarter was a loss
of 28
cents.
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company.
* Neuronetics Inc shares had risen by 16.4% this quarter and
lost 17.0% so far this year.
* The company reported a quarterly loss of $7.61 million.
* Wall Street's median 12-month price target for Neuronetics
Inc
is $9.00
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."
This summary was machine generated from Refinitiv data November
8 at 03:14 p.m. All figures in US dollars unless otherwise
stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Sep. 30 2022 -0.42 -0.28 Beat
Jun. 30 2022 -0.41 -0.39 Beat
Mar. 31 2022 -0.40 -0.41 Missed
Dec. 31 2021 -0.32 -0.29 Beat